Advanced Search >

Risk Minimisation Materials

Bivaluridin Education Material for PCI and Primary PCI

After reconstitution 1ml contains 50mg bivalirudin. After dilution 1ml contains 5mg bivalirudin. Indications: Bivalirudin is indicated as an anticoagulant in adult patients undergoing percutaneous coronary intervention (PCI), including patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI. Bivalirudin is also indicated for the treatment of adult patients with unstable angina/ non-ST segment elevation myocardial infarction (UA/NSTEMI) planned for urgent or early intervention. Bivalirudin should be administered with acetylsalicylic acid and clopidogrel.

For Healthcare Professionals

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue